Searching the Resource Information Network
Are you sure you want to leave this community? Leaving the community will revoke any permissions you have been granted in this community.
Recent advances in human blastoids have opened new avenues for modeling early human development and implantation. One limitation of our first protocol for human blastoid generation was relatively low efficiency. We now report an optimized protocol for the efficient generation of large quantities of high-fidelity human blastoids from naive pluripotent stem cells. This enabled proteomics analysis that identified phosphosite-specific signatures potentially involved in the derivation and/or maintenance of the signaling states in human blastoids. Additionally, we uncovered endometrial stromal effects in promoting trophoblast cell survival, proliferation, and syncytialization during co-culture with blastoids and blastocysts. Side-by-side single-cell RNA sequencing revealed similarities and differences in transcriptome profiles between pre-implantation blastoids and blastocysts, as well as post-implantation cultures, and uncovered a population resembling early migratory trophoblasts during co-culture with endometrial stromal cells. Our optimized protocol will facilitate broader use of human blastoids as an accessible, perturbable, scalable, and tractable model for human blastocysts.
Pubmed ID: 37683605
Publication data is provided by the National Library of Medicine ® and PubMed ®. Data is retrieved from PubMed ® on a weekly schedule. For terms and conditions see the National Library of Medicine Terms and Conditions.
This monoclonal targets p44/42 MAPK (Erk1/2)
View all literature mentionsThis monoclonal targets Human TFAP2C
View all literature mentionsThis unknown targets
View all literature mentionsThis monoclonal targets ZO-1
View all literature mentionsThis monoclonal targets Akt (pan) (C67E7) Rabbit mAb
View all literature mentionsThis monoclonal targets Keratin 7 (D1E4) XP Rabbit mAb
View all literature mentionsThis unknown targets Rabbit IgG (H+L)
View all literature mentionsThis monoclonal targets p70S6K
View all literature mentionsThis polyclonal targets Phospho-Stat3 (Ser727)
View all literature mentionsThis monoclonal targets Phospho-p44/42 MAPK (Erk1/2) (Thr202/Tyr204)
View all literature mentionsThis polyclonal secondary targets IgG (H+L)
View all literature mentionsThis polyclonal secondary targets IgG (H+L)
View all literature mentionsThis polyclonal secondary targets IgG2b
View all literature mentionsThis polyclonal targets Human GATA-6
View all literature mentionsThis monoclonal targets Human, Mouse, Rat, Monkey
View all literature mentionsThis polyclonal secondary targets IgG2b
View all literature mentionsThis polyclonal targets p70 S6 Kinase
View all literature mentionsThis recombinant monoclonal targets NR2F2
View all literature mentionsThis polyclonal targets Human GATA-3 Affinity Purified Ab
View all literature mentionsThis polyclonal secondary targets IgG1
View all literature mentionsThis monoclonal targets Human GATA-6
View all literature mentionsThis polyclonal targets hCG beta antibody
View all literature mentionsThis monoclonal targets AMPK-alpha, phospho (Thr172)
View all literature mentionsThis monoclonal targets Oct-3/4
View all literature mentionsThis recombinant monoclonal targets GATA3
View all literature mentionsThis polyclonal secondary targets IgG (H+L)
View all literature mentionsThis monoclonal targets Phospho-Akt (Ser473)
View all literature mentionsThis monoclonal targets Brachyury / Bry
View all literature mentionsThis unknown targets IgG1
View all literature mentionsThis monoclonal targets Recombinant human sox17, aa 177-414
View all literature mentionsThis polyclonal targets GATA6
View all literature mentionsThis monoclonal targets CDX2
View all literature mentionsThis polyclonal secondary targets IgG (H+L)
View all literature mentionsThis monoclonal targets Sox-2 (E-4)
View all literature mentionsThis polyclonal secondary targets IgG (H+L)
View all literature mentions